Amgen’s (AMGN) “Outperform” Rating Reaffirmed at William Blair
Amgen (NASDAQ:AMGN – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at William Blair in a research report issued on Tuesday,RTT News reports. AMGN has been the subject of a number of other research reports. Johnson Rice set a $294.00 target price on shares of Amgen in a research report on […]
Amgen (NASDAQ:AMGN – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at William Blair in a research report issued on Tuesday,RTT News reports. AMGN has been the subject of a number of other research reports. Johnson Rice set a $294.00 target price on shares of Amgen in a research report on […]
